Recon: Moderna announces bivalent booster more effective than current vaccine; Regeneron acquires Checkmate for $250M
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy